FRESENIUS MEDICAL CARE AG/ DE0005785802 /
2024-10-11 5:29:34 PM | Chg. -0.51 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
36.09EUR | -1.39% | 8,241 Turnover: 298,692.91 |
-Bid Size: - | -Ask Size: - | 10.7 bill.EUR | 3.26% | 21.46 |
GlobeNewswire
06-10
SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
GlobeNewswire
05-07
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
GlobeNewswire
04-24
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
02-23
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
02-04
China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velp...
GlobeNewswire
2023-09-04
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
2023-08-31
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
GlobeNewswire
2023-08-24
CIO Leadership: The Steps Needed to Build a High-Performance Culture Will Power the Discussion at th...
GlobeNewswire
2022-03-29
Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update
GlobeNewswire
2022-03-14
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
GlobeNewswire
2022-03-01
Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results